When
Where
Scandic Holmenkollen Park
Organizer
Open symposium on AI-guided immunotherapy development. Join world-leading researchers at the intersection of artificial intelligence and cancer immunotherapy for a full day of talks, discussion and networking, including a panel moderated by pioneers in the field. The symposium provides an exclusive opportunity to learn about high-throughput functional screening platforms and cutting-edge structural biology alongside the most advanced AI-driven tools for T-cell receptor-target predictions and immune receptor design. Beyond the presentations, it serves as an ideal setting to network with some of the leading minds in T-cell research and bring actionable knowledge back to the Norwegian biotech sector.
Target audience: Researchers, PhD students and postdocs, biotech/pharma and technology transfer office professionals, clinicians, and investors working in the fields of oncology, immunology, biochemistry and molecular biology seeking insights from the forefront of immunology, immunotherapy and cell therapy and protein design.
What You'll Learn: How AI can drive development of new immunotherapies. Insights into cutting-edge functional screening platforms and structural biology alongside the most advanced AI-driven tools for T-cell receptor-target predictions and immune receptor design. Make new connections and bring back knowledge with direct relevance for Norwegian biotech research.